Condition: Intracerebral Hemorrhage · Atrial Fibrillation · Sponsor: Yale University
Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in better functional outcomes as measured by the modified Rankin Scale.
This description comes directly from the study's public registry record.
Kevin N Sheth, MD · 443-615-4729 · kevin.sheth@yale.edu
Hooman Kamel, MD · 646-962-8284 · hok9010@med.cornell.edu
Always discuss trial participation with your own doctor first.
| University of Alabama Hospital | Birmingham, Alabama, United States | Recruiting |
| University of South Alabama University Hospital | Mobile, Alabama, United States | Recruiting |
| Chandler Regional Medical Center | Chandler, Arizona, United States | Withdrawn |
| St. Joseph's Hospital and Medical Center | Phoenix, Arizona, United States | Withdrawn |
| Banner University Medical Center | Tucson, Arizona, United States | Recruiting |
| UAMS Medical Center | Little Rock, Arkansas, United States | Withdrawn |
| Mercy San Juan Medical Center | Carmichael, California, United States | Recruiting |
| Eden Medical Center, Castro Valley | Castro Valley, California, United States | Withdrawn |
| Arrowhead Regional Medical Center | Colton, California, United States | Recruiting |
| Rancho Los Amigos National Rehabilitation Center | Downey, California, United States | Suspended |
| Kaiser Permanente Fontana Medical Center | Fontana, California, United States | Recruiting |
| Community Regional Medical Center of Fresno | Fresno, California, United States | Recruiting |
+ 175 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03907046